PURE Bioscience is a publicly traded company trading on OTC, led by CEO Robert F. Bartlett.
No upcoming earnings scheduled for PURE Bioscience
No earnings announcement scheduled
Past 12 earnings reports for PURE Bioscience
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 16, 2026 | Q2 2026 | -$0.01 | — | $443.0K | — | — |
| Dec 15, 2025 | Q1 2026 | $0.00 | — | $707.0K | — | — |
| Oct 29, 2025 | Q4 2025 | $0.00 | — | $764.0K | — | — |
| Jun 16, 2025 | Q3 2025 | -$0.01 | — | $491.0K | — | — |
| Mar 17, 2025 | Q2 2025 | -$0.01 | — | $391.0K | — | — |
| Dec 16, 2024 | Q1 2025 | -$0.01 | — | $556.0K | — | — |
| Oct 29, 2024 | Q4 2024 | $0.00 | — | $474.0K | — | — |
| Jun 14, 2024 | Q3 2024 | -$0.01 | — | $441.0K | — | — |
| Mar 18, 2024 | Q2 2024 | -$0.01 | — | $326.0K | — | — |
| Dec 14, 2023 | Q1 2024 | -$0.01 | — | $722.0K | — | — |
| Oct 30, 2023 | Q4 2023 | -$0.01 | — | $602.0K | — | — |
| Jun 14, 2023 | Q3 2023 | -$0.01 | — | $406.0K | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.